Product image of Movicol Chocolat (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350) supplied by GNH India

Movicol Chocolat

Active Ingredient:
Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350
Origin:
EU

Movicol Chocolat (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Polyethylene glycol 3350, the active ingredient in Movicol Chocolat, is an osmotic laxative presented as an oral solution for oral use. It is indicated for the relief of constipation and for the management of faecal impaction in adults and children when appropriate.

GNH India supplies Movicol Chocolat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides regulatory‑compliant distribution across multiple markets.

Manufacturer / TM Owner

Norgine Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Movicol Chocolat, an osmotic laxative, is used to treat conditions affecting bowel regularity.

  • Constipation: softens stool and promotes regular bowel movements in patients with functional or chronic constipation.
  • Faecal impaction: facilitates evacuation of hardened stool in cases of acute impaction.
  • Chronic idiopathic constipation: provides long‑term relief by maintaining stool softness for ongoing management.

How It Works

  • Polyethylene glycol 3350 acts as an osmotic agent that is not absorbed from the gastrointestinal tract. It retains water in the intestinal lumen by creating an osmotic gradient, increasing the volume and fluidity of intestinal contents. The resulting softening of stool and increased intraluminal pressure stimulate peristalsis, thereby facilitating the passage of feces.

Side Effects

Polyethylene glycol 3350 may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Abdominal bloating: mild distension of the abdomen.
  • Nausea: feeling of queasiness.
  • Diarrhoea: loose stools occurring after dose.
  • Flatulence: increased intestinal gas.
  • Abdominal cramps: intermittent stomach pain.

Serious or Rare Side Effects

  • Severe electrolyte imbalance: abnormal sodium or potassium levels.
  • Allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Persistent diarrhoea: prolonged watery stools leading to dehydration.

Precautions & Warnings

When prescribing Movicol Chocolat, several safety considerations should be observed.

  • Renal impairment: assess kidney function before use.
  • Electrolyte disorders: monitor serum electrolytes in patients at risk.
  • Pediatric use: adjust dose carefully and supervise children.
  • Concomitant laxatives: avoid simultaneous use of other osmotic agents.
  • Store at ambient temperature: keep below 25 °C, retain original packaging and protect from moisture.

Avoid Interactions

Polyethylene glycol 3350 can interact with other medicines, altering their absorption or electrolyte balance.

Major Interactions (Avoid)

  • Lithium: increased lithium levels due to altered renal clearance.
  • Digoxin: risk of electrolyte‑related toxicity.

Moderate Interactions (Monitor Closely)

  • Diuretics: potential for additive electrolyte loss.
  • Antacids containing magnesium or aluminum: may affect osmotic activity.
  • Oral antibiotics: possible reduction in absorption of the antibiotic.

Frequently Asked Questions

Movicol Chocolat is an oral osmotic laxative indicated for the relief of occasional constipation and for the treatment of faecal impaction. It works by increasing the water content of stool, making it softer and easier to pass, and is used in both adult and pediatric patients when appropriate.

Polyethylene glycol 3350 is a large, non‑absorbable polymer that remains in the gastrointestinal tract. It creates an osmotic gradient that draws water into the intestinal lumen, expanding the stool volume and softening its consistency. The increased fluid pressure stimulates peristalsis, which promotes the evacuation of feces.

The dose of Movicol Chocolat is individualized by the prescribing healthcare professional based on the patient’s age, weight, severity of constipation, and clinical response. The prescriber determines the appropriate amount and frequency, and patients should follow the specific instructions provided on the prescription label.

Safety data for polyethylene glycol‑based laxatives in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it should be prescribed under medical supervision.

To order Movicol Chocolat, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, Movicol Chocolat (polyethylene glycol 3350) works by osmotic water retention rather than stimulating intestinal muscle activity, resulting in a gentler, more physiological stool softening. It is often preferred for long‑term management because it has a lower risk of dependence and fewer cramping side effects.

Store Movicol Chocolat at ambient temperature, preferably below 25 °C. Keep the container in its original packaging, protect it from moisture and direct sunlight, and ensure the seal remains intact to maintain product stability.

Movicol Chocolat is supplied as an oral solution. The recommended practice is to measure the prescribed volume, dilute it in a glass of water if desired, and drink the mixture promptly. It should be taken with or without food as directed by the prescriber.

The most serious risks include severe electrolyte disturbances such as hyponatraemia or hypokalaemia, persistent diarrhoea leading to dehydration, and rare allergic reactions that may present with rash, swelling or breathing difficulty. Patients should seek medical attention if any of these symptoms occur.

Movicol Chocolat should be avoided in individuals with known hypersensitivity to polyethylene glycol or any of its excipients, those with intestinal obstruction, severe renal impairment, or uncontrolled electrolyte disorders. Use under medical supervision is also advised for patients with inflammatory bowel disease or severe dehydration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.